http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008215101-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2e72837de81999e7e72cb78d59d19e28
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36017
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-361
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36082
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-34
filingDate 2007-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be97c7f637944f3835a90392aeea4a33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e10e704ec1af1bc10234f63037a6eb7f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e9ad8c40d222f19d1722f9ee852c52e
publicationDate 2008-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2008215101-A1
titleOfInvention Systems and methods for treating medical conditions by stimulation of medial thalamic region
abstract A system for treating medical conditions by neuromodulation of one or more target sites in the nervous system. In certain embodiments, at least one of the target sites is the medial thalamic region, including the intralaminar nucleus and the adjacent white and grey matter. In certain embodiments, where there is more than one target site, the other target sites is elsewhere in the nervous system, including the globus pallidus interna, subthalamic nucleus, corpus callosum, cerebellum, cerebral cortex (including the premotor cortex, motor cortex, and sensory cortex), ventral striatum, lateral thalamus, substantia nigra, and pedunculopontine nuclei. The medical conditions include movement disorders or improvement of movement function, stroke, neuropsychiatric or neuropsychologic disorders, neurodevelopmental disorders, and pain. Methods for treating medical conditions by neuromodulation of the intralaminar nuclei either alone or in combination with another target site(s) is also provided.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9089688-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8046077-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9713543-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10357657-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005149124-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7974705-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8738154-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8509903-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010312303-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010312304-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8396558-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11202913-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9959388-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7837719-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010204751-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8805515-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9974959-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017176776-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8644919-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8634934-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019513447-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016045739-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9545510-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11040199-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3950049-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015165203-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010141154-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10504496-B1
priorityDate 2006-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7623927-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005010262-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5716377-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003097159-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6937903-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6066163-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002151939-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6167311-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007078498-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006095088-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6463328-B1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID588
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID91670
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127719861
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395300

Total number of triples: 61.